EyePoint Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Corporate Developments

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. APGE
6. DFTX
7. GOOGL
8. MU
9. IBM
10. HOOD

Go back to EyePoint Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Corporate Developments

EyePoint Pharmaceuticals (EYPT) Tops Q2 EPS by 8c

August 2, 2023 7:06 AM EDT

EyePoint Pharmaceuticals (NASDAQ: EYPT) reported Q2 EPS of ($0.61), $0.08 better than the analyst estimate of ($0.69). Revenue for the quarter came in at $9.1 million versus the consensus estimate of $79.11 million.

For earnings history and earnings-related data on EyePoint Pharmaceuticals (EYPT) click here.

... More